0.5 mg Entecavir IP ..

Oct 04, 2023

ENTACOVER 0.5 
Entecavir IP (0.5mg)
Entecavir (brand name Baraclude) is a medication used to treat chronic hepatitis B infection (HBV). The "IP" in "Entecavir IP" might refer to "Inactive Pharmaceutical Ingredient" or "Indian Pharmacopoeia," but it's not a standard abbreviation for this medication.

ENTACOVER 0.5  is an antiviral drug that belongs to a class of medications known as nucleoside analogs. It works by inhibiting the replication of the hepatitis B virus in the body. This helps to reduce the amount of virus in the blood and improve liver function.

Here are some key points to know about Entecavir:

Indication: ENTACOVER 0.5  is used for the treatment of chronic hepatitis B infection in both adults and children who meet specific criteria.

Dosage: The standard dose of Entecavir is typically 0.5 mg once daily for adults and adolescents with normal kidney function. However, the dosage may be adjusted based on factors such as kidney function and the severity of the infection.

Duration of Treatment: Treatment with ENTACOVER 0.5  is generally long-term, often continued for several years or even indefinitely, as determined by a healthcare provider. The goal is to maintain viral suppression and prevent complications of hepatitis B.

Monitoring: Regular monitoring of liver function and viral load is important during treatment to assess the effectiveness of the medication.

Side Effects: Common side effects of ENTACOVER 0.5  may include headache, dizziness, fatigue, and nausea. It's important to report any unusual or severe side effects to a healthcare provider.

Precautions: Entecavir is generally considered safe and effective, but it should not be stopped abruptly without consulting a healthcare provider, as discontinuation can lead to a hepatitis B flare-up.

Pregnancy and Breastfeeding: If you are pregnant or breastfeeding, it's important to discuss the risks and benefits of using Entecavir with your healthcare provider.

It's crucial to take Entecavir as prescribed by a healthcare provider and to follow their instructions carefully. This medication is typically prescribed by specialists in infectious diseases or hepatology (liver diseases) who can monitor your progress and make any necessary adjustments to your treatment plan. If you have questions or concerns about Entecavir or your hepatitis B treatment, be sure to discuss them with your healthcare provider.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
sterisonline.com

SHARE WITH